Evidence map›Paper›PMID 31811214›Full record

ArticleScientific reports2019

Association between daptomycin susceptibility and teicoplanin resistance in Staphylococcus epidermidis.

Shinichi Watanabe, Yukinobu Kawakami, Hiroshi Kimura, Shinobu Murakami, Hitoshi Miyamoto, Shingo Takatori, Koichiro Suemori, Mamoru Tanaka, Akihiro Tanaka, Keiko Tanaka and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Antibacterial Mechanism ofInfection and drug resistance · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Shinichi WatanabeDepartment of Clinical Pharmacy, College of Pharmaceutical Sciences, Matsuyama University, 4-2 Bunkyo-cho, Matsuyama, Ehime, 790-8578, Japan. swatanab@g.matsuyama-u.ac.jp.
Yukinobu KawakamiDivision of Pharmacy, Ehime University Hospital, 454 Shitsukawa, Toon, Ehime, 791-0295, Japan.
Hiroshi KimuraDivision of Pharmacy, Ehime University Hospital, 454 Shitsukawa, Toon, Ehime, 791-0295, Japan.
Shinobu MurakamiDepartment of Infection Control, Ehime University Hospital, 454 Shitsukawa, Toon, Ehime, 791-0295, Japan.
Hitoshi MiyamotoDepartment of Infection Control, Ehime University Hospital, 454 Shitsukawa, Toon, Ehime, 791-0295, Japan.
Shingo TakatoriDepartment of Clinical Pharmacy, College of Pharmaceutical Sciences, Matsuyama University, 4-2 Bunkyo-cho, Matsuyama, Ehime, 790-8578, Japan.
Koichiro SuemoriDepartment of Infection Control, Ehime University Hospital, 454 Shitsukawa, Toon, Ehime, 791-0295, Japan.ORCID http://orcid.org/0000-0002-9154-0162
Mamoru TanakaDivision of Pharmacy, Ehime University Hospital, 454 Shitsukawa, Toon, Ehime, 791-0295, Japan.
Akihiro TanakaDivision of Pharmacy, Ehime University Hospital, 454 Shitsukawa, Toon, Ehime, 791-0295, Japan.
Keiko TanakaDepartment of Epidemiology and Preventive Medicine, Ehime University Graduate School of Medicine, 454 Shitsukawa, Toon, Ehime, 791-0295, Japan.
Hisamichi TauchiDepartment of Infection Control, Ehime University Hospital, 454 Shitsukawa, Toon, Ehime, 791-0295, Japan.
Jun MakiDepartment of Infectious Disease, College of Pharmaceutical Sciences, Matsuyama University, 4-2 Bunkyo-cho, Matsuyama, Ehime, 790-8578, Japan.
Hiroaki ArakiSchool of Pharmacy, Shujitsu University, 1-6-1 Nishigawara, Naka-ku, Okayama, Okayama, 703-8516, Japan.
Takumi YamaguchiDepartment of Clinical Pharmacy, College of Pharmaceutical Sciences, Matsuyama University, 4-2 Bunkyo-cho, Matsuyama, Ehime, 790-8578, Japan.
Ehime University Hospital · JPMatsuyama University · JPShujitsu University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Staphylococcus epidermidis infections are a common occurrence in hospitals, particularly in catheter-related bloodstream and surgical site infections and infective endocarditis. Higher daptomycin minimum inhibitory concentration (MIC) values may be associated with daptomycin treatment failure among patients with S. epidermidis infections. We therefore conducted a retrospective cohort study to determine the predictive value of daptomycin susceptibility. A retrospective study was undertaken in 1,337 patients with S. epidermidis infections. Data were collected from 1 January 2013 to 31 December 2016 at Ehime University Hospital, and included the following clinicopathological factors for evaluation: age, sex, resistance to vancomycin or teicoplanin, and history of antimicrobial therapy. Multiple analysis was performed using logistic regression to identify factors that independently and significantly affected the daptomycin resistance. Daptomycin-resistant S. epidermidis was identified in 38 (2.8%) patients. According to the multiple analysis, only higher MIC values (≥16 mg/L) for teicoplanin (P < 0.0001) were independently associated with an increased risk of developing daptomycin resistance. In conclusion, higher teicoplanin MIC values may predict resistance to daptomycin treatment in S. epidermidis infections.

Indexed as

Drug Resistance, BacterialAgedAnti-Bacterial AgentsCatheter-Related InfectionsDaptomycinDose-Response Relationship, DrugEndocarditis, BacterialFemaleHumansMaleMicrobial Sensitivity TestsMiddle AgedPredictive Value of TestsRetrospective StudiesStaphylococcal InfectionsStaphylococcus epidermidisAnti-Bacterial AgentsDaptomycinTeicoplanin

Identifiers

PMID31811214
PMCPMC6898446
OpenAlexW2992133006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.